Authors:
TAN PZ
SOARES J
BALDWIN RM
VANDYCK C
SOUFER R
SEIBYL JP
CHARNEY DS
INNIS RB
Citation: Pz. Tan et al., H-2 AND F-18 DUAL-LABELED ALTANSERIN AS A METABOLICALLY RESISTANT PETLIGAND FOR SEROTONIN-2A (5-HT2A) RECEPTOR, The Journal of nuclear medicine, 39(5), 1998, pp. 74-74
Authors:
VANDYCK CH
TAN PZ
STALEY J
BALDWIN RM
ALTIKRITI M
GARG PK
NG CK
SOUFER R
CHARNEY DS
INNIS RB
Citation: Ch. Vandyck et al., PET QUANTIFICATION OF 5-HT2A RECEPTORS - A CONSTANT INFUSION PARADIGMWITH [F-18] ALTANSERIN, The Journal of nuclear medicine, 39(5), 1998, pp. 535-535
Authors:
VANDYCK CH
TAN PZ
BALDWIN RM
RAMSBY Q
RICH DA
GARG PK
NG CK
SOUFER R
CHARNEY DS
INNIS RB
Citation: Ch. Vandyck et al., PET QUANTIFICATION OF 5-HT2A C RECEPTORS IN THE HUMAN BRAIN - A CONSTANT INFUSION PARADIGM WITH [F-18] ALTANSERIN/, The Journal of nuclear medicine, 38(5), 1997, pp. 354-354
Authors:
TAN PZ
BALDWIN RM
VANDYCK CH
AMICI L
ALTIKRITI M
ROTH B
KHAN N
FOWLER JS
SHEA C
SOUFER R
CHARNEY DS
INNIS RB
Citation: Pz. Tan et al., IDENTITY AND RECEPTOR-BINDING OF RADIOMETABOLITES OF THE 5-HT2A 2C LIGAND [F-18] ALTANSERIN/, The Journal of nuclear medicine, 38(5), 1997, pp. 1206-1206
Citation: Pz. Tan et al., RAPID SYNTHESIS OF [F-18] SR46349B, A POTENT AND SELECTIVE 5-HT2 RECEPTOR ANTAGONIST, Journal of labelled compounds & radiopharmaceuticals, 36(8), 1995, pp. 719-728